News | June 01, 2011

Volcano Denies Claims in St. Jude OCT Lawsuit

June 1, 2011 – If at first you don’t succeed, try, try again. That is what St. Jude Medical is doing after one court rejected its claims that Volcano Corp. developed an optical coherence tomography (OCT) intravascular imaging system using technology it took from St. Jude.

Earlier this year, the Massachusetts Superior Court rejected claims by LightLab Imaging, a wholly-owned subsidiary of St. Jude Medical, that Volcano’s wholly-owned subsidiary, Axsun Technologies, misappropriated LightLab's confidential OCT system information for use in the development of Volcano's (OCT) system. Axsun manufactures components for LightLab’s OCT system.

Now LightLab is bringing similar claims in a new lawsuit filed May 24 in a Delaware court, in which LightLab alleges that Axsun is wrongfully participating in Volcano's development of an alternative OCT light source, including initiatives underway with third parties. Volcano issued a statement this week denying the claims, calling them “unfounded allegations” and saying that the latest lawsuit has no merit.

Volcano has CE mark for an OCT system in Europe and said it eventually wants to bring the technology to the United States. St. Jude purchased LightLab in the spring of 2010 just after LightLab became the first company in the United States to gain U.S. Food and Drug Administration (FDA) approval for an intravascular OCT system.

OCT offers higher resolution than intravascular ultrasound (IVUS), which is the current standard for intravascular imaging used in coronary and peripheral vessel interventional procedures.

Related Content

The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.

The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.

News | Optical Coherence Tomography (OCT) | October 01, 2020
October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D mi
Explanation of optical coherence imaging (OCT) coronary imaging.
Feature | Optical Coherence Tomography (OCT) | September 17, 2020 | Aziz Maksoud M.D., FACC, FSCAI, and Bassem Chehab, M.D., FACC, FSCAI
Although not a new technology,...
Abbott OCT intravascular imaging explained.
News | Optical Coherence Tomography (OCT) | June 26, 2020
June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed...
Abbott Initiates ILUMIEN IV Trial
News | Optical Coherence Tomography (OCT) | April 11, 2018
Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent...
OCT, optical coherence tomography, coronary stent implantation, superior resolution, TCT 2016, ILLUMIEN III OPTIMIZE PCI Trial
News | Optical Coherence Tomography (OCT) | October 31, 2016
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary...
Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award
News | Optical Coherence Tomography (OCT) | September 27, 2016
Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans...
OCT, ORBID study
News | Optical Coherence Tomography (OCT) | May 16, 2016
May 16, 2016 — In a new study using...